| [1] |
Heitz-Mayfield LJA, Salvi GE, et al. Peri-implant mucositis[J]. J Periodontol, 2018, 89(Suppl1):257-266.
|
| [2] |
Caton JG, Armitage G, Berglundh T, et al. A new classification scheme for periodontal and peri-implant diseases and conditions: Introduction and key changes from the 1999 classification[J]. J Clin Periodontol, 2018, 45(Suppl20):S1-S8.
|
| [3] |
Carra MC, Blanc-Sylvestre N, Courtet A, et al. Primordial and primary prevention of peri-implant diseases: A systematic review and meta-analysis[J]. J Clin Periodontol, 2023, 50:77-112.
doi: 10.1111/jcpe.v50.S26
|
| [4] |
Valles C, Vilarrasa J, Barallat L, et al. Efficacy of soft tissue augmentation procedures on tissue thickening around dental implants: A systematic review and meta-analysis[J]. Clin Oral Implants Res, 2022, 33(S23):72-99.
doi: 10.1111/clr.v33.s23
|
| [5] |
Tavelli L, Barootchi S, Avila-Ortiz G, et al. Peri-implant soft tissue phenotype modification and its impact on peri-implant health: A systematic review and network meta-analysis[J]. J Periodontol, 2021, 92(1):21-44.
doi: 10.1002/jper.v92.1
|
| [6] |
Thoma DS, Naenni N, Figuero E, et al. Effects of soft tissue augmentation procedures on peri-implant health or disease: A systematic review and meta-analysis[J]. Clin Oral Implants Res, 2018, 29(Suppl):32-49.
|
| [7] |
王兴, 王丽萍, 王勤涛, 等. 口腔种植生物学并发症防治专家共识[J]. 口腔医学, 2025, 45(11):801-807.
|
| [8] |
Hosseini M, Worsaae N, Gotfredsen K. Tissue changes at implant sites in the anterior maxilla with and without connective tissue grafting: A five-year prospective study[J]. Clin Oral Implants Res, 2020, 31(1):18-28.
|
| [9] |
Lin CY, Chen Z, Pan WL, et al. Impact of timing on soft tissue augmentation during implant treatment: A systematic review and meta-analysis[J]. Clin Oral Implants Res, 2018, 29(5):508-521.
doi: 10.1111/clr.2018.29.issue-5
|
| [10] |
Poli PP, Maridati PC, Stoffella E, et al. Influence of timing on the horizontal stability of connective tissue grafts for buccal soft tissue augmentation at single implants: A prospective controlled pilot study[J]. J Oral Maxillofac Surg, 2019, 77(6):1170-1179.
doi: 10.1016/j.joms.2019.02.030
|
| [11] |
Thoma DS, Gil A, Hämmerle CHF, et al. Management and prevention of soft tissue complications in implant dentistry[J]. Periodontol 2000, 2022, 88(1):116-129.
doi: 10.1111/prd.12415
pmid: 35103320
|
| [12] |
Jia P, Guo X, Ye J, et al. Microbiome of diseased and healthy implants-a comprehensive microbial data analysis[J]. Front Cell Infect Microbiol, 2024, 14:1445751.
doi: 10.3389/fcimb.2024.1445751
|
| [13] |
文言, 王宇蓝. 菌斑生物膜与种植体周围炎相关研究进展[J]. 口腔疾病防治, 2024, 32(9):730-736.
doi: 10.12016/j.issn.2096-1456.202330512
|
| [14] |
Lin GH, Chan HL, Wang HL. The significance of keratinized mucosa on implant health:A systematic review[J]. J Periodontol, 2013, 84(12):1755-1767.
doi: 10.1902/jop.2013.120688
|
| [15] |
Frisch E, Ziebolz D, Vach K, et al. The effect of keratinized mucosa width on peri-implant outcome under supportive postimplant therapy[J]. Clin Implant Dent Relat Res, 2015, 17:e236-244.
|
| [16] |
王典, 许赞赞, 刘银辉. 宿主口腔微生物组与种植体周围炎相关性的研究进展[J]. 中国微生态学杂志, 2025, 37(6):741-744.
|
| [17] |
Wennström JL, Derks J. Is there a need for keratinized mucosa around implants to maintain health and tissue stability?[J]. Clin Oral Implants Res, 2012, 23:136-146.
doi: 10.1111/clr.2012.23.issue-s6
|
| [18] |
Bawankar PV, Kolte AP, Kolte RA. Peri-implant soft tissue stability through vestibular extension procedure:A retrospective study[J]. Quintessence Int, 2022, 53(3):226-235.
|
| [19] |
Linkevicius T, Apse P. Biologic width around implants. An evidence-based review[J]. Stomatologija, 2008, 10(1):27-35.
|
| [20] |
Schminke B, Vom Orde F, Gruber R, et al. The pathology of bone tissue during peri-implantitis[J]. J Dent Res, 2015, 94(2):354-361.
doi: 10.1177/0022034514559128
pmid: 25406169
|
| [21] |
苏文祺, 张丹丹, 程艳, 等. 基于菌斑控制的种植体周围炎引导骨再生治疗随访7年1例[J]. 华西口腔医学杂志, 2025, 43(1):133-139.
|
| [22] |
吴昊, 刘洪臣, 鄂玲玲, 等. 种植体周围炎对颌骨成骨细胞生物学功能的影响[J]. 华西口腔医学杂志, 2014, 32(2):130-133.
|
| [23] |
Jakub M, Polina N, Monika PG. Periprosthetic inflammation: From the cellular level to clinical implications[J]. JBMR Plus, 2025, 9(11):ziaf154.
|
| [24] |
Esposito M, Grusovin MG, Worthington HV. Interventions for replacing missing teeth:Treatment of peri-implantitis[J]. Cochrane Database Syst Rev, 2012, 1(1):CD004970.
|
| [25] |
张雁君, 袁泉, 杨醒眉. 种植体周微生物及其免疫应答的研究进展[J]. 中国实用口腔科杂志, 2021, 14(5):599-603.
|
| [26] |
Zhang Q, Xu H, Bai N, et al. Matrix metalloproteinase 9 is regulated by LOX-1 and erk1/2 pathway in dental peri-implantitis[J]. Curr Pharm Biotechnol, 2020, 21(9):862-871.
doi: 10.2174/1389201021666200221121139
|
| [27] |
Mardegan GP, Shibli JA, Roth LA, et al. Transforming growth factor-β, interleukin-17, and IL-23 gene expression profiles associated with human peri-implantitis[J]. Clin Oral Implants Res, 2017, 28(7):e10-e15.
|
| [28] |
Li H, Chen Z, Zhong X, et al. Mangiferin alleviates experimental peri-implantitissuppressing interleukin-6 production and Toll-like receptor 2 signaling pathway[J]. J Orthop Surg Res, 2019, 14(1):325.
doi: 10.1186/s13018-019-1387-3
|
| [29] |
Deng S, Hu Y, Zhou J, et al. TLR4 mediates alveolar bone resorption in experimental peri-implantitis through regulation of CD45+ cell infiltration, RANKL/OPG ratio, and inflammatory cytokine production[J]. J Periodontol, 2020, 91(5):671-682.
doi: 10.1002/JPER.18-0748
pmid: 31489644
|